These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

384 related items for PubMed ID: 10197845

  • 1. E-cadherin expression as a marker of tumor aggressiveness in routinely processed radical prostatectomy specimens.
    De Marzo AM, Knudsen B, Chan-Tack K, Epstein JI.
    Urology; 1999 Apr; 53(4):707-13. PubMed ID: 10197845
    [Abstract] [Full Text] [Related]

  • 2. Expression of E-cadherin in prostate cancer in formalin-fixed, paraffin-embedded tissues: correlation with pathological features.
    Köksal IT, Ozcan F, Kiliçaslan I, Tefekli A.
    Pathology; 2002 Jun; 34(3):233-8. PubMed ID: 12109783
    [Abstract] [Full Text] [Related]

  • 3. The relative mRNA expression levels of matrix metalloproteinase to E-cadherin in prostate biopsy specimens distinguishes organ-confined from advanced prostate cancer at radical prostatectomy.
    Kuniyasu H, Ukai R, Johnston D, Troncoso P, Fidler IJ, Pettaway CA.
    Clin Cancer Res; 2003 Jun; 9(6):2185-94. PubMed ID: 12796385
    [Abstract] [Full Text] [Related]

  • 4. E-cadherin expression in prostate cancer: a broad survey using high-density tissue microarray technology.
    Rubin MA, Mucci NR, Figurski J, Fecko A, Pienta KJ, Day ML.
    Hum Pathol; 2001 Jul; 32(7):690-7. PubMed ID: 11486167
    [Abstract] [Full Text] [Related]

  • 5. Identification and characterization of nodal metastases in prostate cancer patients at high risk for lymph node involvement.
    Isebaert S, Haustermans K, Van den Bergh L, Joniau S, Dirix P, Oyen R, Deroose CM, Van Poppel H, Lerut E.
    Acta Oncol; 2013 Oct; 52(7):1336-44. PubMed ID: 23879650
    [Abstract] [Full Text] [Related]

  • 6. Prediction of outcome after radical prostatectomy in men with organ-confined Gleason score 8 to 10 adenocarcinoma.
    Rioux-Leclercq NC, Chan DY, Epstein JI.
    Urology; 2002 Oct; 60(4):666-9. PubMed ID: 12385930
    [Abstract] [Full Text] [Related]

  • 7. Radical prostatectomy in high-risk prostate cancer: incidence of specimen-confined disease (pT2-pT3a N0R0) and outcomes.
    Mearini L, Nunzi E, Bini V, Lepri L, Bruno R, Porena M.
    Urologia; 2014 Oct; 81(2):125-32. PubMed ID: 24474543
    [Abstract] [Full Text] [Related]

  • 8. The percent of cores positive for cancer in prostate needle biopsy specimens is strongly predictive of tumor stage and volume at radical prostatectomy.
    Sebo TJ, Bock BJ, Cheville JC, Lohse C, Wollan P, Zincke H.
    J Urol; 2000 Jan; 163(1):174-8. PubMed ID: 10604340
    [Abstract] [Full Text] [Related]

  • 9. The Role of Prostate-specific Antigen Persistence After Radical Prostatectomy for the Prediction of Clinical Progression and Cancer-specific Mortality in Node-positive Prostate Cancer Patients.
    Bianchi L, Nini A, Bianchi M, Gandaglia G, Fossati N, Suardi N, Moschini M, Dell'Oglio P, Schiavina R, Montorsi F, Briganti A.
    Eur Urol; 2016 Jun; 69(6):1142-8. PubMed ID: 26749093
    [Abstract] [Full Text] [Related]

  • 10. A multivariable analysis of clinical factors predicting for pathological features associated with local failure after radical prostatectomy for prostate cancer.
    D'Amico AV, Whittington R, Malkowicz SB, Schnall M, Tomaszewski J, Schultz D, Kao G, VanArsdalen K, Wein A.
    Int J Radiat Oncol Biol Phys; 1994 Sep 30; 30(2):293-302. PubMed ID: 7928457
    [Abstract] [Full Text] [Related]

  • 11. Role of microvessel density in predicting recurrence in pathologic Stage T3 prostatic adenocarcinoma.
    Gettman MT, Pacelli A, Slezak J, Bergstralh EJ, Blute M, Zincke H, Bostwick DG.
    Urology; 1999 Sep 30; 54(3):479-85. PubMed ID: 10475358
    [Abstract] [Full Text] [Related]

  • 12. Androgen receptor expression in prostate cancer lymph node metastases is predictive of outcome after surgery.
    Sweat SD, Pacelli A, Bergstralh EJ, Slezak JM, Cheng L, Bostwick DG.
    J Urol; 1999 Apr 30; 161(4):1233-7. PubMed ID: 10081876
    [Abstract] [Full Text] [Related]

  • 13. Radical prostatectomy represents an effective treatment in patients with specimen-confined high pathological Gleason score prostate cancer.
    Lughezzani G, Gallina A, Larcher A, Briganti A, Capitanio U, Suardi N, Lista G, Abrate A, Sangalli MN, Buffi N, Cestari A, Guazzoni G, Rigatti P, Montorsi F.
    BJU Int; 2013 May 30; 111(5):723-30. PubMed ID: 22487441
    [Abstract] [Full Text] [Related]

  • 14. Impact of positive surgical margins on prostate-specific antigen failure after radical prostatectomy in adjuvant treatment-naïve patients.
    Ploussard G, Agamy MA, Alenda O, Allory Y, Mouracade P, Vordos D, Hoznek A, Abbou CC, de la Taille A, Salomon L.
    BJU Int; 2011 Jun 30; 107(11):1748-54. PubMed ID: 20883488
    [Abstract] [Full Text] [Related]

  • 15. Is tumor volume an independent predictor of progression following radical prostatectomy? A multivariate analysis of 185 clinical stage B adenocarcinomas of the prostate with 5 years of followup.
    Epstein JI, Carmichael M, Partin AW, Walsh PC.
    J Urol; 1993 Jun 30; 149(6):1478-81. PubMed ID: 8501792
    [Abstract] [Full Text] [Related]

  • 16. Prognostic value of seminal vesicle involvement due to prostate cancer in radical prostatectomy specimens.
    Algarra R, Barba J, Merino I, Tienza A, Tolosa E, Robles JE, Zudaire J.
    Actas Urol Esp; 2015 Apr 30; 39(3):144-53. PubMed ID: 24996780
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Utility of tissue microarrays for profiling prognostic biomarkers in clinically localized prostate cancer: the expression of BCL-2, E-cadherin, Ki-67 and p53 as predictors of biochemical failure after radical prostatectomy with nested control for clinical and pathological risk factors.
    Nariculam J, Freeman A, Bott S, Munson P, Cable N, Brookman-Amissah N, Williamson M, Kirby RS, Masters J, Feneley M.
    Asian J Androl; 2009 Jan 30; 11(1):109-18. PubMed ID: 19050681
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.